En formation initiale : Outre le tutorat des fonctionnaires stagiaires et l’accompagnement des étudiants en stage (stages d’observation, stages de pratique accompagnée), les PEMF devront intervenir prioritairement dans les ESPE, au sein d’équipes pluri-professionnelles. Ils seront aussi amenés à accompagner les stagiaires en M2, dans leur travail de recherche, dans le cadre du mémoire professionnel et à participer à des dispositifs de recherche-action initiés dans les ESPE.
Results: Low-back pain scores for the 42-µs group decreased by 40.2% (p = 0.028), compared to 18.6% for the 38-µs pulse width group (p = 0.037) and 25.6% for the sham group (p = 0.013 per protocol population). Average leg pain scores decreased by 45.0% (42 μs, p = 0.009), 17.0% (38 μs, p = 0.293), and 24.5% (sham, p = 0.065). The proportion of subjects responding to therapy, time to 30% reduction in pain scores, and Patient Global Impression of Change were improved with the PEMF 42-μs device over the sham control, although results were associated with p-values >0.05.
The information provided in this website should not be misconstrued as medical advice or instruction. No action should be taken based solely on the contents of information provided. Readers should consult appropriate health professionals on any matter relating to their health and well being. The information and opinions provided here are believed to be accurate and sound, based on the best judgement available to authors. This device is not intended to diagnose, treat, or cure any disease.

Within the domain of shoulder pain, rotator cuff conditions can be caused by an inter-relationship between soft tissue laxity (i.e. ligament) resulting in glenohumeral laxity, impingement (e.g. due to bursitis or osteophytes) resulting in tendon compression and cuff lesions (Allingham & McConnell 2003). Therefore, treatment is likely to be more effective when all possible factors that can cause laxity, impingement or lesion of the cuff are considered. These include:
Pulsed Electromagnetic Field Therapy (PEMF or PEMT) is a non-invasive, painless treatment which works by emitting a pulsating, varying intensity and frequency electromagnetic field, coming from a solenoid placed around the patient. Pulsed electromagnetic field therapy was approved by the FDA in 1979 specifically for the healing of nonunion fractures, which came after a Columbia University study that was encouraged by NASA, and has recently gained attention in the U.S (even appearing as a segment on the Dr. Oz Show). The value of pulsed electromagnetic field therapy has been shown to cover a wide range of conditions, with well documented trials carried out by hospitals, rheumatologists, physiotherapists, and neurologists. PEMF was widely used and with great success in the 19th and early 20th century. These primitive electromagnetic therapeutic devices were used by both medical doctors and non-allopathic health practitioners.
On the show, world-class pain specialist Dr. James Dillard mentioned electromagnetic portable pads to Dr. Oz. These mats produce a therapeutic pulsed electromagnetic field that can surround the entire body. They are not FDA-approved and are not made in the USA. PEMF mats are primarily advertised and distributed over the Internet, often used without medical supervision. Retail price is $2000 to $3000, and often renting is possible for a weekly rate. There are a dozen different companies that make these devices. Three examples are the Mediconsult iMRS/MRS2000, Medithera Home System, and Quantron Resonance System QRS-101.
PEMF allows for almost immediate increase in vascular flow, enhancing circulation and reducing edema, such as in the series on a nasal defect demonstrated in Figure 7. Another important use of PEMF configured for the Ca/CaM/NO pathway is in the treatment of chronic nonhealing wounds. The recommended treatment is 30 minutes twice per day until the wound is closed. Closure of chronically open wounds may be seen in 6 to 10 weeks with this treatment (Figures 8 and 9).
The PEMF devices described in this review (Ivivi Technologies, Montvale, NJ) have been cleared by the FDA for the treatment of postoperative pain and edema and are currently available. PEMF therapy is typically used for postoperative pain management with the expectation of a significant reduction in the use of narcotics and/or nonsteroidal antiinflammatory drugs, earlier hospital discharge, and/or an earlier return to function. As indicated in this review, PEMF may also be used in challenging cases such as irradiated tissue or other wounds in poorly vascularized tissue. In practice, PEMF is delivered via a circular coil that is always placed so that the tissue target is encompassed within the coil perimeter. The device can be applied over dressings, braces, or clothing. Treatment regimens may be manual or automatic. For postoperative use, treatment begins in the recovery room and is generally administered every 4 hours for 30 minutes for 3 days, and then every 8 hours for the next several days until pain and edema are not significant. For the treatment of chronic wounds, the regimen is 30 minutes twice a day until healed. PEMF device operation is simple and patients may easily be instructed on its use in both outpatient and home settings.
The development of modern PEMF has followed two separate pathways. The first pathway originated in more conventional (and still useful) electromagnetic field technologies broadly known as radio frequency (RF) diathermy.4 Continuous RF produces heat, the therapeutic component frequently employed in physical therapy. One early user of diathermy suspected that it could produce a nonthermal biologic effect.5 To test this idea clinically, the RF signal was intermittently pulsed, thereby eliminating heat. Positive outcomes, especially in treating inflammatory conditions, were reported.5 The first therapeutic RF PEMF device, the Diapulse, was commercialized in 19506 and was eventually cleared by the U.S. Food and Drug Administration (FDA) for the postoperative treatment of pain and edema in soft tissue. Clinical devices in use since that time typically have consisted of a large signal generator and a bulky coil applicator positioned over the area of injury that delivers therapy noninvasively, through either dressings or clothing. Early devices were expensive, nonportable, and produced significant electromagnetic interference (EMI); these factors restricted more widespread use in outpatient and home settings.
Results: Low-back pain scores for the 42-µs group decreased by 40.2% (p = 0.028), compared to 18.6% for the 38-µs pulse width group (p = 0.037) and 25.6% for the sham group (p = 0.013 per protocol population). Average leg pain scores decreased by 45.0% (42 μs, p = 0.009), 17.0% (38 μs, p = 0.293), and 24.5% (sham, p = 0.065). The proportion of subjects responding to therapy, time to 30% reduction in pain scores, and Patient Global Impression of Change were improved with the PEMF 42-μs device over the sham control, although results were associated with p-values >0.05.
Today we provide the largest variety of PEMF therapy products to the UK (with a few other health products to make it even better!). As a family run business we aim to provide our customers with honest, educational and trustworthy information. We believe that everyone needs PEMF therapy in his or her life, it’s not just a management tool, it’s prevention tool too. We like to think of it as our first aid kit!

My interest in PST began in 1995 when a Journal of Rheumatology article suggested that it might alleviate my 15 year old daughter's pain caused by an arthritic condition. Although unable to walk without crutches, two weeks after a course of PST her pain was relieved and she could walk unassisted. A month later she was able to pursue all athletic activities without discomfort. She subsequently enrolled in a martial arts class, recently attained black belt status, and has continued to remain symptom free without the need for any drugs or further treatment for the past five years.
Pulsed electromagnetic field (PEMF) therapy isn’t typically as well-known as other forms of treatment such as chiropractic, massage, and physical therapy. Therefore, many people assume that it’s a relatively new remedy, leaving it wide open for speculation when it comes to its positive effects. However, the truth is, PEMF has actually been used to help people live a healthier life for quite a long time.
Many people are aware of the negative effects Electro Magnetic Fields have but it is important to understand not all Electro Magnetic fields are bad and in the case of PEMF therapy we are using them to recharge our cells. Each cell in the body has its own small electromagnetic field with all our cells operating between around 0-30Hz. The Earth also has a magnetic field fundamental resonance frequency which is usually around 7.83Hz which is referred to the Schumann Frequency and this is the type of magnetic field our bodies have evolved to operate properly in. The problem is with increasing technology our world is getting filled with electromagnetic pollution that is filled with higher frequency electromagnetic fields our bodies are unable to properly function with and is making us sick.

Alzheimer’s disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields; Sandyk R; Int J Neurosci. 1994 Jun;76(3-4):185-225. The author had previously reported that external application of electromagnetic fields (EMF) of extremely low intensity (in the picotesla range) and of low frequency (in the range of 5Hz-8Hz) improved visual memory and visuoperceptive functions in patients with Parkinson's disease. Since a subgroup of Parkinsonian patients, specifically those with dementia, have coexisting pathological and clinical features of AD, the author investigated in two AD patients the effects of these extremely weak EMF on visual memory and visuoconstructive performance. The Rey-Osterrieth Complex Figure Test as well as sequential drawings from memory of a house, a bicycle, and a man were employed to evaluate the effects of EMF on visual memory and visuoconstructive functions, respectively. In both patients treatment with EMF resulted in a dramatic improvement in visual memory and enhancement of visuoconstructive performance which was associated clinically with improvement in other cognitive functions such as short term memory, calculations, spatial orientation, judgement and reasoning as well as level of energy, social interactions, and mood. The report demonstrates, for the first time, that specific cognitive symptoms of AD are improved by treatment with EMF of a specific intensity and frequency. The rapid improvement in cognitive functions in response to EMF suggests that some of the mental deficits of AD are reversible being caused by a functional (i.e., synaptic transmission) rather than a structural (i.e., neuritic plaques) disruption of neuronal communication in the central nervous system.


Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients; Rektorova; J Neurol Sci. 2005 Mar 15;229-230:157-61 This study aimed to examine whether one session of high frequency repetitive transcranial magnetic stimulation (rTMS) applied over the left dorsolateral prefrontal cortex (DLPFC) would induce any measurable cognitive changes in patients with cerebrovascular disease and mild cognitive deficits. Seven patients with cerebrovascular disease and mild executive dysfunction entered the randomized, controlled, blinded study with a crossover design. rTMS was applied either over the left DLPFC (an active stimulation site) or over the left motor cortex (MC; a control stimulation site) in one session. Each patient participated in both stimulation sessions (days 1 and 4) and the order of stimulation sites (DLPFC or MC) was randomized. A short battery of neuropsychological tests was performed by a blinded psychologist prior to and after each rTMS session. Psychomotor speed, executive function, and memory were evaluated. Results: mild but significant stimulation site-specific effect of rTMS was observed in the Stroop interference results (i.e. improvement) after the stimulation of DLPFC in comparison with the baseline scores (Wilcoxon, Z=-2.03, p=0.04). Patients improved in the digit symbols subtest of the Wechsler adult intelligence scale-revised after both rTMS sessions regardless of the stimulation site.
Results: Low-back pain scores for the 42-µs group decreased by 40.2% (p = 0.028), compared to 18.6% for the 38-µs pulse width group (p = 0.037) and 25.6% for the sham group (p = 0.013 per protocol population). Average leg pain scores decreased by 45.0% (42 μs, p = 0.009), 17.0% (38 μs, p = 0.293), and 24.5% (sham, p = 0.065). The proportion of subjects responding to therapy, time to 30% reduction in pain scores, and Patient Global Impression of Change were improved with the PEMF 42-μs device over the sham control, although results were associated with p-values >0.05.
Fracture nonunion: a rare but extremely serious complication. “Normally a broken bone will begin to grow together in a few weeks if the ends are held close together to each other without movement. Occasionally, however, a bone will refuse to knit despite a year or more of casts and surgery. This is a disaster for the patient and a bitter defeat for the doctor, who must amputate the arm or leg and fit a prosthetic substitute.” Becker
There is currently a lack of guidelines based on randomized, prospective studies to aid the clinician treating partial rotator cuff tears and contusions. Also, most of the available studies lack adequate statistical power. The results of nonoperative management of partial-thickness tears are largely unknown because there are no long-term follow-up studies using a standardized treatment protocol. Nonsurgical treatment is still regarded as the initial management step. The goal of treatment in athletes with a partial rotator cuff tear is to eliminate pain and restore function. Treatment of the athlete with a rotator cuff contusion has the same objective. The goals could evolve if biologic interventions are developed that lead to a true healing response (Ferhat et al, 2016).
The primary purpose of this website is to give those interested in PEMF's (pulsed electromagnetic fields) insights into the fundamental significance, the scientific background and the effects of the increasingly popular complementary medical application of PEMF's. In the last 5 years much has been accomplished and positively changed specifically in the field of PEMF systems for home use.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
No medical or purported medical claims are being made, no diagnosis, promises of results, or a "treatment" or "cure" is being represented, made, promised or promoted by the manufacturer whatsoever. No medical advice, instruction, or information whatsoever has been or will be given by the manufacturer. This is section is for informational purposes only. Individual results may vary. Please consult your Physician before using this, or any other related product.
Lie on the PEMF mat for approximately 30 minutes a day to maximize your benefit from the sessions. You can always split the 30 minutes into smaller time periods if you cannot stay on the mat for that time. This being said, every mat is made differently and this instruction is just a general guideline. Follow the recommendations on the instructions for your PEMF mat for optimal results.
“The PEMF Therapy and all the other treatments by Dr Pacelli is the best decision I could have made! In the 4 months I’ve seen huge improvements in my health. The psoriasis is diminishing…my energy has greatly improved…my color is wonderful…my weight is decreasing…my blood sugars are totally normal…and I’ve shown my medical doctors that I don’t need the Statin drug they were trying to force on me…because my LDL and cholesterol levels are now totally normal.
Enseignement transmissif : L'enseignement transmissif, communément associé aux méthodes dites traditionnelles, est une approche de l'enseignement dans laquelle l'élève est récepteur d'un savoir donné par le maître. La séance d'enseignement transmissif commence par la règle qui est donnée "toute faite" par le maître. Une fois la règle expliquée, l'élève exécute des exercices d'application de la règle. L'élève rencontre souvent des difficultés à réutiliser spontanément les règles qu'il a travaillées dans des exercices où il n'avait que cela à penser. C'est pourquoi les méthodes traditionnelles le complétaient par une pratique très régulière de la rédaction et des problèmes de mathématiques concrets.
×